Background/Aims: To assess the possible contribution of the β-adrenergic overstimulation in early stages of renal injury, the present study evaluated, in rats, the effects of the β-adrenoceptor agonist isoproterenol (ISO) on renal function and morphology, as well as the renal mRNA and protein expression of the NADPH oxidase isoform 4 (Nox 4) and subunit p22 phox , endoplasmic reticulum (ER) stress, pro-inflammatory, pro-apoptotic and renin-angiotensin system (RAS) components. Methods: Wistar rats received ISO (0.3 mg.kg -1
Introduction
In physiological condition, the sympathetic nervous system (SNS) provides a critical aspect in the maintenance of homeostasis through the cardiac function and peripheral resistance control. In this condition, the blood pressure and the vascular tone ensure specific tissues perfusion [1] . The SNS action depends on the release of neurotransmitters, such as catecholamines, that interact with specific receptors named α-adrenergic (α-AR) and β-adrenergic (β-AR) located in target tissues [2] . The kidneys are innervated by efferent sympathetic nerve fibers, which preferentially release norepinephrine (NE) and contact the wall of the afferent arteriole and tubules [3] , an essential condition that regulates the renal hemodynamic and fluid balance. The β-AR types 1 and 2 have been detected in vascular smooth muscle cells from arteries and arterioles, as well as in proximal and distal tubular cells [4] . Furthermore, the β1-AR is expressed in the juxtaglomerular granular cells, where it regulates the NE action on the renin secretion [5] .
Sympathetic hyperactivity is commonly associated with progression of both cardiovascular and chronic kidney diseases [6, 7] . Although there is no evidence on the specific involvement of β-AR stimulation in the progression of chronic kidney disease, in vitro studies demonstrated that in human embryonic kidney (HEK) cells, the β2-AR signaling is closely related to activation of NADPH oxidase and generation of intracellular reactive oxygen species (ROS) [8] . In addition, NE or isoproterenol acting via β-ARs, stimulates the angiotensinogen gene expression in opossum kidney (OK) proximal tubular cells [5, 9] . These findings are relevant and indicate that in animal models both NE and isoproterenol via β-ARs can stimulate the intrarenal RAS, as well as ROS generation. Furthermore, in various tissues increased ROS production is closely related to the endoplasmic reticulum (ER) stress, inflammatory, fibrotic and apoptotic responses [10] [11] [12] , predictive factors for the progression of chronic kidney disease [10, 13] .
In line with these findings, isoproterenol (ISO) or isoprenaline is a synthetic catecholamine and non-selective β-AR agonist of clinical use, that acutely increase the heart rate and enhance sinoatrial and atrioventricular conduction [14] . However, in animal models, the chronic treatment with ISO causes severe stress to the cardiomyocytes resulting in hypertrophy and myocardial infarct, which are similar to those observed in human [15, 16] and are closely related to oxidative stress and inflammation [17, 18] . In contrast, there are no evidences of the effects of ISO treatment on renal pathophysiology. This is an important question with clinical relevance and limited advance in our knowledge base. Thus, the main purpose of this study was to evaluate if eight-day treatment with ISO induces changes on renal function and morphology in rats, as well as intrarenal oxidative stress, ER stress, inflammation, apoptosis and RAS components expression. Together, these factors can lead to the early stages of renal injury induced by specific β-ARs overstimulation.
Materials and Methods

Animals and study design
All procedures and protocols used in this study were approved by the Institutional Animal Care and Use Committee of the University of São Paulo (protocol n o 71, page 20/03). Male Wistar rats (n = 22), weighing 250 -300 g) were obtained from the animal care facility of the Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo (São Paulo, Brazil). All animals were housed at the department facility under standard conditions (constant temperature of 22°C, 12:12-h light-dark cycle, and 60% relative humidity). The rats were fed standard rat chow and provided water ad libitum. The animals were randomly allocated into the following two groups: control rats (n = 10), which received only vehicle (0.1 ml of soy bean oil, s.c.) and Isoproterenol-treated rats (n = 12), which received (-)-ISO (0.3 mg.kg .day -1 , resuspended in 0.1 ml of soy bean oil, s.c.) (Sigma Aldrich, St. Louis, USA). The rats were treated every 24 hours for eight days.
Physiological parameters
On the eighth day of treatment, the animals were housed individually in metabolic cages for 24 hours and the food (g/day) and water (ml/day) ingestion, as well as urine output (ml/day) were monitored. The body weight (BW) gain was calculated as following: (final BW -initial BW).
Renal function studies
At the end of the treatment, the animals were anesthetized with zoletil (50 mg/kg zolazepan and 50mg/kg tiletamine) and xylazine (5 mg/kg) placed on a warm table to maintain body temperature and tracheostomized using a PE-260 tube to maintain ventilation. As previously described [19, 20] and summarized here, the right carotid artery and right jugular vein were cannulated using a PE-50 catheter (Clay Adams, Franklin Lakes, NJ) for blood sampling and continuous fluid infusion, respectively. The urinary bladder was catheterized using a PE-260 via a suprapubic incision for urine collections. Before clearance experiments, the first urine sample (~1 ml) was collected directly from the urinary bladder of each animal for further analysis of osmolality and determination of electrolyte content. A blood sample was also collected for osmolality and electrolyte analyses. Then, renal hemodynamic and function measurements were performed as described below. The animals received infusion of a isotonic solution (0.9 M NaCl) for 30 min (0.1 ml/min), using an infusion pump (Harvard Instruments, Holliston, MA), followed by infusion of a 1ml bolus containing 90 mg/animal of inulin (Sigma-Aldrich, St. Louis, MO) and 2 mg/animal of sodium para-amino-hypuric acid (PAH; Sigma-Aldrich). After that, 30 min of continuous infusion with control solution containing 15 mg/ml inulin, and 4 mg/ml PAH at 0.1 ml/min (Sigma-Aldrich) was performed to stabilize the experiment. Then, under the same continuous infusion, four consecutive 30-minute urine and arterial blood sample (500 µl) collections were obtained to determine the kidney function.
Plasma and urine inulin and PAH concentrations were evaluated by standard colorimetric techniques using a spectrophotometer (µQuant; Bio-Tek Instruments Inc, Winooski, USA). The renal plasma flow (RPF) and glomerular filtration rate (GFR) were calculated from the PAH [21] and inulin [22] clearance, respectively. The filtration fraction (FF) was obtained as the GFR/RPF ratio and expressed as a percentage (%). The urine volume of each sample was determined for the urine flow measurement (V). The clearance was calculated using the following formula, where C is clearance, x is the urine or plasma concentration of a substance, and V represents urine flow rate: C = (Urine x ·V)/plasma x .
Plasma and urine analysis
The plasma and urine osmolality were measured using an osmometer (Precision Systems, Natick, MA), and sodium concentrations were determined by flame photometry (9180 Electrolyte Analyzer; Roche, Basel, Switzerland). The fractional sodium excretion (FE%) was calculated using the formula: (V [Na ] p is the plasma sodium concentration. The urine protein and creatinine concentrations were also evaluated using the metabolic cage sample and colorimetric tests (Labtest, Lagoa Santa, Brazil). The experiments were carried out following the manufacturer's instructions and urine protein concentration was normalized by 24-hour urine creatinine.
Morphological studies
After the renal function experiments, the kidneys were immediately perfused with PBS (0.15 M NaCl containing 10 mM sodium phosphate buffer, pH 7.4) at 20 ml/min through the distal aorta using a peristaltic perfusion pump (Milan Scientific Equipment, BP 600 PR, Brazil), as previously described [20] . At this condition, euthanasia was performed by exsanguination. One kidney per rat was isolated, removed, weighed and used for the quantitative PCR studies. The remaining kidney was fixed in 4% paraformaldehyde solution, dehydrated and embedded in paraffin for morphological studies. For these assays, 4-µm-thick kidney sections were stained using Verhoeff method and renal morphology was evaluated blindly by two independent persons by using a light microscope (Eclipse 80i, Nikon). For the planar glomerular area analysis, all glomeruli with apparent macula densa and afferent arterioles from the renal cortical area of each rat were included. The area of each glomerulus was determined, and the mean glomeruli areas were obtained using a morphometry software (NIS-Elements D, Nikon, Tokyo, Japan).
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Ventricles and kidney weights Both heart ventricles and one kidney were excised and weighed. The ratio between ventricles or kidney weight (mg) and body weight (g) was used as an index to confirm cardiac or renal hypertrophy.
Renal cortex mRNA expression As previously described [23, 24] and summarized here, after the renal function analysis, one kidney was isolated, snap frozen and pulverized in liquid nitrogen, followed by the isolation of RNA using the TRIzol LS Reagent (Life Technologies, Carlsbad, USA). Then, 2 µg total RNA was used to obtain cDNA (HighCapacity cDNA Reverse Transcription Kit; Life Technologies) and real-time PCR was performed using a StepOnePlus (Life Technologies) machine and TaqMan assay system (Life Technologies). The following TaqMan probes were used: angiotensinogen (Agt), Rn00593114_m1; renin (Ren), Rn00561847_m1; angiotensin I converting enzyme (Ace) Rn00561094_m1; NADPH oxidase isoform 4 (Nox4), Rn00585380_ m1; NADPH oxidase subunit p22 phox (Cyba) Rn00577357_m1; eukaryotic translation initiation factor alpha (Eif2a), Rn01494813_m1; activating transcription factor 4 (Atf4), Rn00824644_g1; nuclear factor kappa B 1 (Nfkb1), Rn01399572_m1; interleukin 1 beta (Il1b), Rn00580432_m1; Bcl2-associated x protein (Bax), Rn02532082_g1; Bcl-2 (Bcl2), Rn99999125_g1 and the reference gene glyceraldehyde-3-phosphate dehydrogenase (Gapdh), Rn01775763_g1. All qPCRs were performed using 20 ng cDNA, and all samples were assayed in duplicate. The comparative cycle threshold (2 -ΔΔCt ) method was used for data analysis. The data were normalized to Gapdh expression and expressed as the fold change relative to the control group.
Immunohistochemical staining
As previously described [25] and summarized here, kidney sections (4-µm thick) were deparaffinized and nonspecific protein binding was blocked by incubation with 10% goat serum in PBS for 60 min. Then, kidney sections were incubated overnight at and subsequently with specific ant-rabbit or anti-mouse secondary antibodies for two hours at room temperature. The reaction products were detected using the avidin-biotin-peroxidase method (Vector Labs, Burlingame, USA) and the sections were counterstained with methyl green (Amresco, Solon OH, USA), dehydrated and mounted with Permount (Fischer Scientific, Fair Lawn, USA). Immunostained proteins were analyzed blindly by one independent person using a computerized morphometry program (NIS-Elements, Nikon). Positive cortical tubules for protein expression were counted in 20 fields (107172, 99 µm 2 ) and the mean count was calculated per kidney.
Statistical analysis
The data were evaluated using Student´s t-test or non parametric test for comparisons between two groups depending on the sampling distribution, using GraphPad Prism Software (GraphPad Softwarw, Inc, San Diego, CA, USA). The results are expressed as the mean ± standard error of the mean (SE) and p<0.05 was considered significant.
Results
Distribution of β-ARs in the kidney
We began confirming the expression and distribution of the β-ARs in the rat kidney tissue (Fig. 1) . The β1-AR immunoreactivity was found mostly in the proximal tubules and collecting ducts, whereas β2-AR immunoreactivity was also observed in the proximal nephron and, to a lesser extent, in the collecting duct cells.
Physiological parameters, ventricles and kidney weight
As shown in Table 1 , eight days of ISO treatment did not change food and water intake, neither the body weight gain or kidney weight. However, ISO treatment induced significant increase of the ventricles weight to body weight ratio, indicating the effectiveness of ISO to induce cardiac hypertrophy. (Fig. 2  A) . Despite reduced glomerular perfusion in ISO-treated rats, the GFR was similar to control group [(ml/min) CTL, 1.81 ± 0.11 versus ISO, 2.06 ± 0.12] (Fig. 2 B) . Consistent with these findings, the FF (GFR/RPF ratio) was significantly increased in ISO-treated rats compared with the control [(%) CTL, 30.52 ± ISO (n = 9-10) Plasma Na + , mEq/L 139 ± 1 140 ± 2 Plasma osmolality, mOsmol/kg H2O 292 ± 5 297 ± 5 CTL (n = 9-10 ) ISO (n = 7-12 ) Urine flow, µL/min Urine osmolality, mOsmol/kg H2O Urine protein-to-creatinine, mg/day 13.06 ± 1.9 274 ± 28 1.57 ± 0. 0.62 versus ISO, 38.42 ± 1.30] (Fig. 2 C) . However, the renal hemodynamic changes did not induce changes in the glomerular area (Table 1) .
Renal hemodynamics and glomerular area
Eight days of ISO treatment significantly decreased RPF compared with control rats [(ml/min) CTL, 6.13 ± 0.21 versus ISO, 5.22 ± 0.30]
Tubular function, urine flow and proteins
As shown in Table 1 , ISO treatment did not change the Na + plasma concentration, plasma or urine osmolality, urine flow or Na + tubular handling compared with the control group. In addition, ISO treatment did not change the urine protein concentration compared with control group.
Intrarenal mRNA and/or protein expression of oxidative stress and endoplasmic reticulum stress components
As shown in Fig. 3 and Table 2 , ISO treatment induced significant increase in cortical mRNA expression of Nox 4 and p22 phox as well as eIF2α and Atf4 when compared with the control rats (A and D). The immunostaining and semiquantitative analysis demonstrate that ISO treatment also induced significant increase of NOX4 and EIF2α expression in the cortical tubular segments, including proximal tubules (B, C, E and F).
Intrarenal mRNA and/or protein expression of inflammatory components
The immunostaining and semiquantitative analysis demonstrate that ISO treatment induced significant increase in the cortical IκB expression when compared with the control group (Fig. 4 A, B and Table 2 ), ISO treatment also induced increase in both mRNA and immunostaing of NFκB1 in comparison to the control group (Fig. 4 C -E and Table 2 ). ISO treatment did not change the mRNA expression of IL-1β (p = 0.152), but it induced a significant increase in the cortical immunostaining of this cytokine when compared with the control group (Fig. 5 A -C) . Representative photomicrographs of the renal cortex, illustrating immunostaining and s e m i q u a n t i t a t i v e analysis of IL-1β (B and C). Kidney sections (4-µm thick) were stained using immunohistochemical method. Standard images were captured using a morphometric program (NIS-Element) with a x 20 objective. Also shown magnifications of positive-stained proximal tubules (PT) for IL-1β from control and ISO treated rats and negative control without primary antibody. Values are means ± SE, (n = 6-8). All qPCR samples were assayed in duplicate.
Intrarenal mRNA and/or protein expression of apoptotic components
As shown in Fig. 6 and Table 2 , eight days of ISO treatment significantly increased the cortical mRNA expression of Bax compared with the control group. In contrast, the mRNA expression of Bcl-2 remained unchanged between groups. In this condition, the Bax/Bcl-2 ratio was significantly increased in ISO treated group when compared with the control (A). The immunostaining and semiquantitative analysis confirmed the stimulatory effect of ISO on BAX content which exceeded BCL-2. However, the BAX/BCL-2 ratio was only slightly higher in the ISO-treated group when compared with the control (p = 0.06) (B and C).
Intrarenal mRNA and/or protein expression of RAS components
Our results showed that ISO treatment induced a significant increase in cortical mRNA expression of angiotensinogen and ACE1 but not renin (p = 0.28) when compared with the control group (Fig. 7 A and Table 2 ). The cortical ACE1, but not angiotensinogen (p = 0.33) or renin (p = 0.53) immunostaining was increased in ISO treated group when compared with the control group (Fig. 7 B -C and Table 2 ). In contrast, ISO treatment induced significant increase in medullar renin content when compared to control rats (Fig. 7 D, E and Table 2 ).
Discussion
Using isoproterenol as a non-selective β-ARs agonist, in the current study we evaluated in vivo, potential mechanisms underlying β-ARs overstimulation and the consequences of this stimulation on the early stages of renal injury.
Studies have revealed that seven days of the β-agonist isoproterenol treatment induces cardiac hypertrophy without changes in blood pressure parameters, but with a significant increase of extracellular matrix remodeling in heart and vascular wall [17, 26] . Our study corroborates these findings since we observed a pronounced ventricular hypertrophy with eight days of isoproterenol treatment.
Considering that we and others [4] observed that β-ARs are well distributed throughout the kidney and that there is little knowledge about the involvement of specific β-ARs stimulation in the progression of chronic kidney disease, we were encouraged to initially investigate whether the stimulation of these receptors by isoproterenol for eight days contributes to changes in renal hemodynamics and tubular function. Our study revealed that despite the absence of changes in glomerular morphology, the ISO treatment induced significant decrease in the RPF and a slight increase (13.3%) in the GFR, suggesting increase of both pre-and post-glomerular resistance. These changes leaded to the increase of FF, as a result of GFR and RPF ratio. Our observations with specific β-ARs stimulation are relevant since the renal vasoconstriction leads to renal ischemia and are in agreement with previous studies in which the hyperactivity of the SNS resulted in increased afferent and efferent arterioles resistance [27, 28] .
Despite evidence on the positive correlation between sympathetic hyperactivity and progression of renal failure [7] , in the current study, specific β-ARs stimulation by ISO treatment was not enough to induce changes in renal sodium handling or urine flow, suggesting maintenance of sodium balance. In addition, the ISO treatment did not change protein excretion. However, preserved tubular function is no guarantee of the absence of early cellular events, which may progress to tubular injury. Studies in vivo and in vitro have highlighted that in cardiomyocytes the β-AR stimulation can activate NAD(P)H oxidase to produce ROS and to induce ER stress, resulting in cellular damage [12, 29] . In the kidney, we observed that ISO treatment induced a significant increase of intrarenal genes encoding NAD(P)H oxidase Nox 4 isoform and p22 phox subunit. In addition, the increased immunostaining analysis confirmed the post-transcriptional effect of ISO on Nox4 mainly in the renal cortex.
Accumulating evidences suggest a crosstalk between the ROS generation and ER stress response. Indeed, Nox 4 can physically interact with the protein disulfide isomerase (PDI), which is involved with protein folding in the ER. In this condition, the ER homeostasis is changed and in the signaling cascade, activation of double-stranded RNA-activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK) leads to phosphorylation of the eukaryotic translation initiation factor alpha (eIF2α) and activation of the transcription factor 4 (ATF4). ATF4, in turn, translocates to the nucleus and upregulates the expression of factors associated with apoptosis and organ injury [30] . In the current study, we observed that prolonged treatment with ISO resulted in significant increase of eIF2α and Atf4 mRNA, as well as eIF2α protein expression specially in tubular cells of renal cortex, suggesting early cellular events which lead to tubular injury.
Previous studies have suggested a cross talk between ROS and/or eIF2α pathway and NFκB activation under many stress conditions. It is known that eIF2α can directly activate NFκB [31] . Furthermore, in response to ER stress, the IRE1α induces IκB phosphorylation leading to nuclear translocation of NFκB1, which promoters a variety of gene transcription, including inflammatory cytokines such as TNF-α and IL-1 and 6 in various tissues [32, 33] . Consistent with these observations, our results provided a link between ER stress/IκB/ NFkB activation and inflammation confirmed by IL-1 β tubular immunostaining in the renal cortex of rats treated with ISO for eight days. Together these factors seem to be essential for the initiation and progression of renal injury.
Furthermore, it is important to note that oxidative stress, ER stress and inflammation have been highlighted as mechanisms involved in renal tubular cells apoptosis [34] . The Bax to Bcl-2 ratio indicates the susceptibility of a cell to apoptosis [35] . In the current study, we demonstrated that the treatment with ISO resulted in significant increase of Bax in both mRNA and protein levels, and it also increased the Bax/Bcl ratio in RNAm levels, suggesting that the β-adrenergic stimulation by ISO combined with intrarenal ROS, ER stress and inflammation could induce apoptosis in the cortical tubular cells and contribute to the progression of renal injury.
With reference to the intrarenal RAS, various studies demonstrated the renal tubular expressiom of angiotensinogen, renin and ACE1 [36] [37] [38] [39] . In vitro studies have reported effect of ISO on gene expression of angiotensinogen [5, 9] . However, there is no evidence whether β-ARs stimulation by ISO changes the expression of these molecules in vivo. Our in vivo study revealed that ISO treatment induced increase of cortical mRNA expression of both angiotensinogen and ACE1. Furthermore, ISO treatment induced increase in the protein levels of cortical ACE1 and medullar renin, suggesting a potential contribution of ISO on intrarenal RAS stimulation.
Conclusion
The results of the current study showed that eight days of β-adrenergic stimulation with ISO induced changes in renal hemodynamic and increased intrarenal ROS production, ER stress, inflammation, apoptosis and RAS components expression. Taken together, our findings provide relevant information regarding the contribution of specific β-adrenergic hyperactivity on early stage of renal injury, suggesting that, in addition to cardiac hypertrophy, it may be also an important risk factor for the development of kidney diseases.
